Abstract：
OBJECTIVES:More than 1.5 million patients worldwide are affected by bone metastases. Patients with bone metastases frequently develop skeletal-related events (SREs, including radiation to bone, non-vertebral fracture, vertebral fracture, surgery to bone, and spinal cord compression) that are associated with high healthcare costs. This study aims to provide an estimate of the cost per SRE in both the inpatient and outpatient settings in Belgian patients with bone metastases secondary to solid tumors (breast, prostate, and lung cancers). METHODS:Patients were retrieved from the IMS Hospital Disease database from 2005-2007. Inclusion was based on the International Classification of Diseases and Related Health Problems Version 9 (ICD-9) diagnosis and/or procedure codes covering patients with breast, prostate, or lung cancer with bone metastases who were hospitalized for one or more SREs. All costs were extrapolated to 2010 using progression in hospitalization costs since 2001. Additional outpatient costs resulting from radiation to bone and diagnostic tests performed in ambulatory settings were estimated by combining published unit costs with resource use data obtained from a Delphi panel. RESULTS:The average cost per SRE across solid tumor types based on the weighted average of inpatient and outpatient costs was €2653 for radiation to bone, €5015 for a vertebral fracture, and €7087 for a non-vertebral fracture. Costs were €12,885 and €15,267 for surgery to bone and spinal cord compression, respectively. LIMITATIONS:No patient follow-up across calendar years could be done. Also, details regarding the exact anatomic sites of SREs were not always available. CONCLUSIONS:SREs add a substantial cost to the management of patients with bone metastases. Avoiding SREs can lead to important cost-savings for the healthcare payer.
journal_name
J Med Econjournal_title
Journal of medical economicsauthors
Body JJ,Chevalier P,Gunther O,Hechmati G,Lamotte Mdoi
10.3111/13696998.2013.774279subject
Has Abstractpub_date
2013-01-01 00:00:00pages
539-46issue
4eissn
1369-6998issn
1941-837Xjournal_volume
16pub_type
杂志文章abstract：OBJECTIVE:Abdominal paracentesis is commonly performed for diagnostic, therapeutic, and palliative indications, but the use of ultrasound guidance for these procedures is relatively recent, variable, and not well documented. A retrospective database analysis of abdominal paracentesis procedures was performed to determi...
journal_title：Journal of medical economics
pub_type： 杂志文章
doi：10.3111/13696998.2011.628723
更新日期：2012-01-01 00:00:00
abstract：OBJECTIVE:To describe costs, healthcare resource utilization, and adherence of US patients receiving human regular U-500 insulin (U-500R), compared to patients receiving high-dose (>200 units/day) U-100 insulins (U-100) by subcutaneous injection for the treatment of diabetes. METHODS:A retrospective analysis of data f...
journal_title：Journal of medical economics
pub_type： 杂志文章
doi：10.3111/13696998.2013.772059
更新日期：2013-01-01 00:00:00
abstract：OBJECTIVE:The treatment of iron deficiency (ID) with ferric carboxymaltose (FCM) improves the functional class and quality of life of chronic heart failure (CHF) patients with reduced left ventricular ejection fraction (LVEF), and reduces the rate of hospitalization due to worsening CHF. This study aims to evaluate the...
journal_title：Journal of medical economics
pub_type： 杂志文章
doi：10.1080/13696998.2020.1838872
更新日期：2020-10-30 00:00:00
abstract：OBJECTIVE:The aim of this study was to evaluate medication adherence and persistence of patients treated with Etanercept and Adalimumab for Rheumatoid Arthritis, also giving economic evaluations on therapy costs for Received Daily Dose (RDD). MATERIALS AND METHODS:This retrospective study took into account 6 years fro...
journal_title：Journal of medical economics
pub_type： 杂志文章
doi：10.3111/13696998.2014.902844
更新日期：2014-05-01 00:00:00
abstract：OBJECTIVES:To describe treatment patterns and healthcare burden among individuals with suspected pulmonary arterial hypertension (PAH), as identified through a practice guideline-based healthcare claims algorithm. METHODS:Adults with evidence of PAH from 1 January 2004 (commercial and Medicaid) or 1 July 2006 (Medicar...
journal_title：Journal of medical economics
pub_type： 杂志文章
doi：10.3111/13696998.2012.690801
更新日期：2012-01-01 00:00:00
abstract：AIMS:Depression is the most frequent comorbidity reported among patients with rheumatoid arthritis (RA). Comorbid depression negatively impacts RA patients' health-related quality-of-life, physical function, mental function, mortality, and experience of pain and symptom severity. The objective of this study was to asse...
journal_title：Journal of medical economics
pub_type： 杂志文章
doi：10.1080/13696998.2019.1572015
更新日期：2019-04-01 00:00:00
abstract：OBJECTIVE:To assess patient characteristics, treatment patterns, and healthcare resource utilization (HRU)/costs of individuals treated for neuroendocrine tumors (NETs) in the US. METHODS:Using a US administrative claims database, this study identified commercially-insured adults newly diagnosed with carcinoid tumors ...
journal_title：Journal of medical economics
pub_type： 杂志文章
doi：10.3111/13696998.2014.975233
更新日期：2015-02-01 00:00:00
abstract：OBJECTIVES:To perform a cost-utility analysis of a new formulation of mesalazine (Mezavant XL, MMX mesalazine) versus an existing oral mesalazine (Asacol; mesalazine) from the UK National Health Service perspective. METHODS:A 5-year Markov cohort model was developed. Costs were obtained from the literature and utiliti...
journal_title：Journal of medical economics
pub_type： 杂志文章
doi：10.3111/13696990903562861
更新日期：2010-03-01 00:00:00
abstract：AIMS:This paper evaluates the impact of multiple sclerosis (MS) in Ireland, and estimates the associated direct, indirect, and intangible costs to society based on a large nationally representative sample. MATERIALS AND METHODS:A questionnaire was developed to capture the demographics, disease characteristics, healthc...
journal_title：Journal of medical economics
pub_type： 杂志文章
doi：10.1080/13696998.2018.1427100
更新日期：2018-05-01 00:00:00
abstract：OBJECTIVE:To compare all-cause and diabetes-related resource utilization and healthcare charges among adults with type 2 diabetes mellitus who initiated therapy with mealtime insulin disposable pens or vials. METHODS:Data were obtained from the Innovus inVision database from January 1, 2006 through June 30, 2010. Gene...
journal_title：Journal of medical economics
pub_type： 杂志文章
doi：10.3111/13696998.2013.823091
更新日期：2013-10-01 00:00:00
abstract：OBJECTIVE:To assess predictors and costs of multiple sclerosis (MS) relapse, a potential outcome measure in payer-manufacturer risk-sharing agreements for disease-modifying drugs (DMDs). METHODS:A retrospective cohort analysis of medical/pharmacy claims was used. Study patients had ≥1 DMD (interferon beta, glatiramer,...
journal_title：Journal of medical economics
pub_type： 杂志文章
doi：10.3111/13696998.2013.823868
更新日期：2013-09-01 00:00:00
abstract：OBJECTIVE:Prostate cancer is a leading cause of cancer death in men in the US. Castration-resistant prostate cancer (CRPC) is an advanced form of the disease and has a poor prognosis and limited treatment options. The objective of this study was to identify patients with CRPC from a medical claims database, and determi...
journal_title：Journal of medical economics
pub_type： 杂志文章
doi：10.3111/13696998.2010.491435
更新日期：2010-01-01 00:00:00
abstract：OBJECTIVE:The only effective treatment for severe aortic stenosis (AS) is valve replacement. However, many patients with co-existing conditions are ineligible for surgical valve replacement, historically leaving medical management (MM) as the only option which has a poor prognosis. Transcatheter Aortic Valve Replacemen...
journal_title：Journal of medical economics
pub_type： 杂志文章,随机对照试验
doi：10.3111/13696998.2013.770747
更新日期：2013-01-01 00:00:00
abstract：BACKGROUND:Non-vitamin K antagonist oral anticoagulants (NOACs) have been included in international guidelines as important alternatives to vitamin K antagonists (VKAs) for the treatment of venous thromboembolism (VTE) and stroke prevention in non-valvular atrial fibrillation (NVAF). Meanwhile, in the Netherlands, NOAC...
journal_title：Journal of medical economics
pub_type： 杂志文章,多中心研究
doi：10.1080/13696998.2018.1563404
更新日期：2019-04-01 00:00:00
abstract：:Aims: To evaluate costs in patients with diabetes who experienced a macrovascular complication from a Brazilian public healthcare system perspective.Materials and methods: A retrospective, observational study that utilized the database of the Brazilian Unified Health System (DATASUS). Data for direct medical costs (ho...
journal_title：Journal of medical economics
pub_type： 杂志文章
doi：10.1080/13696998.2020.1764966
更新日期：2020-09-01 00:00:00
abstract：OBJECTIVE:To compare rates of severe relapse and total direct and indirect costs over a 2-year period between US-based employees with multiple sclerosis (MS) who were adherent and non-adherent to disease-modifying drugs (DMDs). METHODS:Employees with ≥1 MS diagnosis (ICD-9-CM: 340.x) and ≥1 DMD pharmacy claim between ...
journal_title：Journal of medical economics
pub_type： 杂志文章
doi：10.3111/13696998.2012.667027
更新日期：2012-01-01 00:00:00
abstract：OBJECTIVE:A new and smaller percutaneous ventricular assist device (pVAD, Impella, Abiomed, Danvers, MA) has been developed to provide circulatory support in hemodynamically unstable patients and to prevent hemodynamic collapse during high-risk percutaneous coronary interventions (PCI). The objective of the study was t...
journal_title：Journal of medical economics
pub_type： 杂志文章
doi：10.3111/13696998.2012.762004
更新日期：2013-01-01 00:00:00
abstract：:Objectives: To describe the clinical characteristics, treatment pattern, and medical costs associated with metastatic castration-resistant prostate cancer (mCRPC) in Chinese patients. Methods: This retrospective study identified a group of patients with newly-developed mCRPC from 2012 to 2016 to extract information fr...
journal_title：Journal of medical economics
pub_type： 杂志文章
doi：10.1080/13696998.2019.1600524
更新日期：2019-08-01 00:00:00
abstract：OBJECTIVE:The purpose of this study was to determine the cost effectiveness (from a payer's perspective) of adding clostridial collagenase ointment (CCO) to selective debridement compared with selective debridement alone (non-CCO) in the treatment of stage IV pressure ulcers among patients identified from the US Wound ...
journal_title：Journal of medical economics
pub_type： 杂志文章
doi：10.1080/13696998.2016.1252381
更新日期：2017-03-01 00:00:00
abstract：OBJECTIVE:To characterize patient and physician satisfaction with current standard-of-care botulinum toxin treatment regimens for symptom control in patients with post-stroke spasticity using structured interviews with patients and physicians. RESEARCH DESIGN AND METHODS:Two cross-sectional surveys were conducted in C...
journal_title：Journal of medical economics
pub_type： 杂志文章
doi：10.3111/13696998.2014.925462
更新日期：2014-09-01 00:00:00
abstract：BACKGROUND:Inhibitor development to factor VIII (FVIII) hemophilia therapy results in increased complications and substantial economic costs. The SIPPET study, the first randomized controlled trial to compare the immunogenicity of plasma-derived FVIII (pdFVIII)/von Willebrand factor (VWF) and recombinant-DNA-derived FV...
journal_title：Journal of medical economics
pub_type： 杂志文章,随机对照试验
doi：10.1080/13696998.2018.1468335
更新日期：2018-08-01 00:00:00
abstract：OBJECTIVE:To estimate the economic implications of introducing dabigatran etexilate ('dabigatran') for anti-coagulation therapy in Danish patients with non-valvular atrial fibrillation based on results of the RE-LY trial. METHODS:The lifetime cost and outcomes of dabigatran and warfarin were estimated using a previous...
journal_title：Journal of medical economics
pub_type： 杂志文章
doi：10.3111/13696998.2012.673525
更新日期：2012-01-01 00:00:00
abstract：OBJECTIVE:To review, summarize, and analyze both similarities and differences of pharmacoeconomic (PE) guidelines, to enable researchers to access their characteristics and the current state of PE guidelines; furthermore, to learn which methodological issues still remain contested and to promote the methodological deve...
journal_title：Journal of medical economics
pub_type： 杂志文章,评审
doi：10.1080/13696998.2017.1387118
更新日期：2018-01-01 00:00:00
abstract：OBJECTIVE:The Affordable Care Act (ACA) established the Hospital-Acquired Condition (HAC) Reduction Program. The Centers for Medicare and Medicaid Services (CMS) established a total HAC scoring methodology to rank hospitals based upon their HAC performance. Hospitals that rank in the lowest quartile based on their HAC ...
journal_title：Journal of medical economics
pub_type： 杂志文章,评审
doi：10.1080/13696998.2017.1396993
更新日期：2018-01-01 00:00:00
abstract：BACKGROUND:Growing financial pressure on US dialysis providers requires economic efficiency considerations. The objective of this study was to examine short-term economic efficiencies of a cinacalcet-based treatment approach for secondary hyperparathyroidism. METHODS:This study retrospectively assessed cost per bioche...
journal_title：Journal of medical economics
pub_type： 杂志文章,随机对照试验
doi：10.3111/13696998.2013.826665
更新日期：2013-09-01 00:00:00
abstract：OBJECTIVES:To assess the cost effectiveness of palivizumab, a humanised monoclonal antibody, used as prevention against severe respiratory syncytial virus (RSV) infection requiring hospitalisation, in infants with haemodynamically significant congenital heart disease (CHD) in the German healthcare setting. STUDY DESIG...
journal_title：Journal of medical economics
pub_type： 杂志文章
doi：10.3111/13696990903347172
更新日期：2009-01-01 00:00:00
abstract：:Aims: This article aimed to examine the cost-effectiveness of rivaroxaban in comparison to warfarin for stroke prevention in Japanese patients with non-valvular atrial fibrillation (NVAF), from a public healthcare payer's perspective.Materials and methods: Baseline event risks were obtained from the J-ROCKET AF trial ...
journal_title：Journal of medical economics
pub_type： 杂志文章
doi：10.1080/13696998.2019.1688821
更新日期：2020-03-01 00:00:00
abstract：OBJECTIVES:To determine the cost effectiveness of sevelamer vs calcium carbonate in patients with chronic kidney disease and not on dialysis (CKD-ND) from the perspective of the National Health Service (NHS) in the UK. METHODS:A Markov decision analytic model was developed to estimate (1) total life years (LYs), quali...
journal_title：Journal of medical economics
pub_type： 杂志文章
doi：10.3111/13696998.2013.792267
更新日期：2013-01-01 00:00:00
abstract：BACKGROUND:Patients with unresectable, metastatic colorectal cancer with wild type Kirsten ras mutational status are eligible for sequential treatments which include monoclonal antibodies as first line (1L), second line (2L), or third line (3L) regimens. OBJECTIVE:To compare the economic outcomes of different sequence...
journal_title：Journal of medical economics
pub_type： 杂志文章
doi：10.3111/13696998.2013.864973
更新日期：2014-02-01 00:00:00
abstract：OBJECTIVE:To compare the persistence and costs of brimonidine versus brinzolamide therapy according to data collected by the UK General Practitioner Research Database (GPRD). METHODS:Patients with diagnoses of ocular hypertension or glaucoma, or treated for glaucoma by surgery or laser therapy were identified. Selecte...
journal_title：Journal of medical economics
pub_type： 杂志文章
doi：10.3111/13696990802211107
更新日期：2008-01-01 00:00:00
